货号:GS40627
Rovalpituzumab is an antibody-drug conjugate (ADC) targeting delta-like protein 3 (DLL3), a Notch ligand family member highly expressed on the surface of small cell lung cancer (SCLC) and other neuroendocrine tumors. It delivers a cytotoxic payload (typically a DNA-damaging agent) directly to DLL3-positive cancer cells, inducing cell death.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物